Clinical practice patterns in the management of dry eye disease: A TFOS international survey 2023-24

被引:0
作者
Wolffsohn, James S. [1 ,2 ,3 ]
Semp, David A. [1 ]
Dutta, Debarun [1 ]
Jones, Lyndon [3 ]
Craig, Jennifer P. [1 ,2 ,3 ]
机构
[1] Aston Univ, Coll Hlth & Life Sci, Optometry & Vis Sci Res Grp, Birmingham, England
[2] Univ Auckland, Aotearoa New Zealand Natl Eye Ctr, Dept Ophthalmol, Auckland, New Zealand
[3] Univ Waterloo, Ctr Ocular Res & Educ CORE, Sch Optometry & Vis Sci, Waterloo, ON, Canada
关键词
Management; Therapy; Dry eye disease; Subtype; Severity; Ocular surface; Tear film; OPTOMETRISTS; THERAPY;
D O I
10.1016/j.jtos.2024.12.008
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aims: To understand current clinical management of dry eye disease (DED), based on its perceived severity and subtype, by practitioners across the world. Methods: The content of the anonymous survey was chosen to reflect the DED management strategies reported by the Tear Film and Ocular Surface Society (TFOS) second Dry Eye Workshop (DEWS II). Questions were designed to ascertain practitioner treatment choice, depending on the subtype and severity of DED. It was first created in English and then translated/back-translated into 14 languages for online completion. Results: Completed surveys were received from 905 eye care practitioners (52 % optometrists and 42 % ophthalmologists) from across the globe. Many treatment strategies for DED were observed to be utilised by respondents, independent of severity and subtype, the most common being advice (82 %), low (82%) and high (81 %) viscosity unpreserved lubricants and lid wipes/scrubs (79 %). Several treatments were prescribed across all severity levels (scaled from 1 mild to 10 severe), such as advice (median 4.5, range 4.8), artificial tears (median 5.1, range 4.6) and nutritional supplements (median 5.3, range 4.2). Others were prescribed more frequently with increasing disease severity, for instance, biologics (median 8.2, range 2.8) and surgical approaches (median 8.1, range 2.2). While a similar number of practitioners reported prescribing advice, artificial tears and antiinflammatories regardless of DED subtype, the commonly reported approaches for aqueous deficient DED were punctal occlusion, therapeutic contact lenses and secretagogues, while the use of oral essential fatty acids, topical lipid-containing products, lid hygiene and lid warming were the preferred management choices for evaporative DED. Conclusions: There remains great variability in clinical approaches to DED management and until research- evidence definitively informs improved guidance, data from this survey may be useful for clinicians to benchmark their practice.
引用
收藏
页码:164 / 172
页数:9
相关论文
共 28 条
  • [1] Stapleton F., Alves M., Bunya V.Y., Jalbert I., Lekhanont K., Malet F., Et al., TFOS DEWS II Epidemiology report, Ocul Surf, 15, pp. 334-365, (2017)
  • [2] Craig J.P., Nichols K.K., Akpek E.K., Caffery B., Dua H.S., Joo C.-K., Et al., TFOS DEWS II definition and classification report, Ocul Surf, 15, pp. 276-283, (2017)
  • [3] Schiffman R.M., Walt J.G., Jacobsen G., Doyle J.J., Lebovics G., Sumner W., Utility assessment among patients with dry eye disease, Ophthalmology, 110, pp. 1412-1419, (2003)
  • [4] Li M., Gong L., Sun X., Chapin W.J., Anxiety and depression in patients with dry eye syndrome, Curr Eye Res, 36, pp. 1-7, (2011)
  • [5] Luo Y., Yang W., Qi M., Wang Y., Li S., Wang M., Et al., Annual direct economic burden and influencing factors of dry eye disease in Central China, (2021)
  • [6] McDonald M., Patel D.A., Keith M.S., Snedecor S.J., Economic and Humanistic burden of dry eye disease in Europe, North America, and Asia: a Systematic Literature review, Ocul Surf, 14, pp. 144-167, (2016)
  • [7] Morthen M.K., Magno M.S., Utheim T.P., Snieder H., Hammond C.J., Vehof J., The physical and mental burden of dry eye disease: a large population-based study investigating the relationship with health-related quality of life and its determinants, Value Health, 21, pp. 107-117, (2021)
  • [8] Jones L., Downie L.E., Korb D., Benitez-del-Castillo J.M., Dana R., Deng S.X., Et al., TFOS DEWS II management and therapy report, Ocul Surf, 15, pp. 575-628, (2017)
  • [9] Wolffsohn J.S., Arita R., Chalmers R., Djalilian A., Dogru M., Dumbleton K., Et al., TFOS DEWS II Diagnostic methodology report, Ocul Surf, 15, pp. 539-574, (2017)
  • [10] Essa L., Laughton D., Wolffsohn J.S., Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms? Cont Lens Anterior Eye, 41, pp. 60-68, (2018)